PPARG and asthma: Despite recent evidence that PPAR-γ promotes Th2 cell functions in mice and humans (91, 93), preclinical studies had repeatedly shown that PPAR-γ agonists reduced goblet cell metaplasia, alarmin release and airway hyperresonsiveness in mouse models of asthma (141–144).